Analyst Ratings for Galena Biopharma (GALE)

GALE Rating Summary

GALE Price Target Summary

* Over Last 12-Mos
  |   Expand Research on GALE
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $4.08 (+136%) * Over Last 12-Mos
Rating Score: 8.6 / 10   Percentile Rank: 90%
Date Firm Type Rating
(Past)
PT
(Past)
Start $ End $ % Chg. Details
12/8/2015 Cantor Fitzgerald Upgrade Hold
(Sell)
2.00
(N/A)
1.52 1.73 13.82% Details
11/12/2015 Oppenheimer
» Updated 1/22/2016
Upgrade Outperform
(Perform)
4.00
(N/A)
1.46 1.73 18.49% Details
Like GALE Ratings? Also take a look at PBMD, OPXA, ORMP, ORPN

GALE Ratings News